Cogent Biosciences, Inc. (COGT) Operating cash flow 2017–2025
Cogent Biosciences, Inc. (COGT) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$264.4MFY2025 · since FY2017: -$25.8M → -$264.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$264.4M | -27.3% |
| FY2024 | -$207.8M | -35.3% |
| FY2023 | -$153.6M | -29.5% |
| FY2022 | -$118.6M | -101.9% |
| FY2021 | -$58.8M | -63.9% |
| FY2020 | -$35.9M | +13.6% |
| FY2019 | -$41.5M | -27.8% |
| FY2018 | -$32.5M | -25.8% |
| FY2017 | -$25.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice